Filed: 8/14/2026ACC: 0001831942-26-000033
📋 What this filing means
COMMODORE CAPITAL LP filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $1.68B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$1.68B
Total AUM (reported)
106.09M
Total Shares
Allocation by class
COM$934.22M55.6%
COM NEW$343.09M20.4%
COM SHS$214.63M12.8%
SHS$157.19M9.4%
CLASS A ORD SHS$19.18M1.1%
ORD SHS CL A$5.35M0.3%
USD CL A ORD SHS$5.32M0.3%
Portfolio Concentration
Top 3$547.91M32.6%
4–10$596.75M35.5%
11–25$478.67M28.5%
Rest$55.63M3.3%
Top 3 weight
32.6%
Top 10 weight
68.2%
Voting Authority Distribution
Total shares with voting rights: 106.09M
Sole
Full voting authority
106.09M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole33
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings33
Rows:
RELAY THERAPEUTICS INC
SOLEShares12M
TypeSH
Market value$224.52M
13.37%
Sole
12M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares3.27M
TypeSH
Market value$166.21M
9.90%
Sole
3.27M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares3M
TypeSH
Market value$157.19M
9.36%
Sole
3M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares3.05M
TypeSH
Market value$118.03M
7.03%
Sole
3.05M
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares5.65M
TypeSH
Market value$101.47M
6.04%
Sole
5.65M
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares2M
TypeSH
Market value$94.08M
5.60%
Sole
2M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares846.79K
TypeSH
Market value$75.18M
4.48%
Sole
846.79K
Shared
0.00
None
0.00
ALTO NEUROSCIENCE INC
SOLEShares2.72M
TypeSH
Market value$71.87M
4.28%
Sole
2.72M
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares2.25M
TypeSH
Market value$70.33M
4.19%
Sole
2.25M
Shared
0.00
None
0.00
EYEPOINT INC
SOLEShares4.60M
TypeSH
Market value$65.78M
3.92%
Sole
4.60M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares1.88M
TypeSH
Market value$59.89M
3.57%
Sole
1.88M
Shared
0.00
None
0.00
DAMORA THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$50.43M
3.00%
Sole
1.94M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares1.35M
TypeSH
Market value$50.23M
2.99%
Sole
1.35M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares1.43M
TypeSH
Market value$49.28M
2.93%
Sole
1.43M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares1.50M
TypeSH
Market value$48.68M
2.90%
Sole
1.50M
Shared
0.00
None
0.00
ASSEMBLY BIOSCIENCES INC
SOLEShares1.42M
TypeSH
Market value$38.88M
2.32%
Sole
1.42M
Shared
0.00
None
0.00
EDITAS MEDICINE INC
SOLEShares8.89M
TypeSH
Market value$28.80M
1.72%
Sole
8.89M
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares250K
TypeSH
Market value$28.67M
1.71%
Sole
250K
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares6.34M
TypeSH
Market value$21.61M
1.29%
Sole
6.34M
Shared
0.00
None
0.00
CENTURY THERAPEUTICS INC
SOLEShares8.70M
TypeSH
Market value$21.30M
1.27%
Sole
8.70M
Shared
0.00
None
0.00
ZURA BIO LTD
SOLEShares3.25M
TypeSH
Market value$19.18M
1.14%
Sole
3.25M
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares1.02M
TypeSH
Market value$18.82M
1.12%
Sole
1.02M
Shared
0.00
None
0.00
INFLARX NV
SOLEShares7.30M
TypeSH
Market value$16.35M
0.97%
Sole
7.30M
Shared
0.00
None
0.00
AN2 THERAPEUTICS INC
SOLEShares2.93M
TypeSH
Market value$14.20M
0.85%
Sole
2.93M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares100K
TypeSH
Market value$12.35M
0.74%
Sole
100K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RELAY THERAPEUTICS INCSOLE | COM | 12M | SH | $224.52M 13.37% | 12M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 3.27M | SH | $166.21M 9.90% | 3.27M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 3M | SH | $157.19M 9.36% | 3M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 3.05M | SH | $118.03M 7.03% | 3.05M | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 5.65M | SH | $101.47M 6.04% | 5.65M | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 2M | SH | $94.08M 5.60% | 2M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 846.79K | SH | $75.18M 4.48% | 846.79K | 0.00 | 0.00 |
ALTO NEUROSCIENCE INCSOLE | COM SHS | 2.72M | SH | $71.87M 4.28% | 2.72M | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 2.25M | SH | $70.33M 4.19% | 2.25M | 0.00 | 0.00 |
EYEPOINT INCSOLE | COM NEW | 4.60M | SH | $65.78M 3.92% | 4.60M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 1.88M | SH | $59.89M 3.57% | 1.88M | 0.00 | 0.00 |
DAMORA THERAPEUTICS INCSOLE | COM NEW | 1.94M | SH | $50.43M 3.00% | 1.94M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 1.35M | SH | $50.23M 2.99% | 1.35M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 1.43M | SH | $49.28M 2.93% | 1.43M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.50M | SH | $48.68M 2.90% | 1.50M | 0.00 | 0.00 |
ASSEMBLY BIOSCIENCES INCSOLE | COM NEW | 1.42M | SH | $38.88M 2.32% | 1.42M | 0.00 | 0.00 |
EDITAS MEDICINE INCSOLE | COM | 8.89M | SH | $28.80M 1.72% | 8.89M | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 250K | SH | $28.67M 1.71% | 250K | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 6.34M | SH | $21.61M 1.29% | 6.34M | 0.00 | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 8.70M | SH | $21.30M 1.27% | 8.70M | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 3.25M | SH | $19.18M 1.14% | 3.25M | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 1.02M | SH | $18.82M 1.12% | 1.02M | 0.00 | 0.00 |
INFLARX NVSOLE | COM | 7.30M | SH | $16.35M 0.97% | 7.30M | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 2.93M | SH | $14.20M 0.85% | 2.93M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 100K | SH | $12.35M 0.74% | 100K | 0.00 | 0.00 |
Page 1 of 2